What’s going on with movies these days? Every time you hear the old “people don’t want to go to movie theaters anymore” line, it seems a Moana 2 shows up to knock those naysayers back down in their ...

YouTube has released its top trending lists for 2024. The roundup includes the top songs, creators, and topics from the year. YouTube Trending is a data-driven report that replaced YouTube Rewind in ...

Democratic National Committee Chair Ken Martin on Thursday released the party’s autopsy report on the 2024 election after facing intense pressure to do so. Subscribe to read this story ad-free Get ...

CNN is publishing a copy of a report into why Democrats lost the 2024 presidential election conducted at the request of Democratic National Committee Chair Ken Martin. This version of the report – ...

For the most part, voting patterns across demographic groups in the 2024 presidential election were not substantially different from the 2020 and 2016 elections. But Donald Trump’s gains among several ...

National health expenditures are projected to have grown 8.2 percent in 2024 and to increase 7.1 percent in 2025, reflecting continued strong growth in the use of health care services and goods.

The latest State of JavaScript survey provides an up-close look at the JavaScript language features, tools, libraries, and frameworks developers are using and how they're using them. Getting a ...

Sara Resende is a Portuguese list writer for Collider, specializing in comedy shows and biopic movies, which she loves for their entertaining take on historical events. She also has a passion for ...

2024 was a huge year for film franchises, according to IMDb's end-of-year rankings — but few original works cut through the noise. IMDb, the entertainment database, measures the popularity of titles ...

For stock investors, 2024 was an expectedly great year. Behind the continued bull market for stocks was solid economic growth, falling inflation, Federal Reserve interest-rate cuts, and healthy ...

The FDA’s Center for Drug Evaluation and Research (CDER) approved 50 new small molecules, biologics and oligonucleotide therapeutics last year. The class of 2024 was a little smaller than that of 2023 ...